| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000426312 |
| P356 | DOI | 10.2165/00002018-199819050-00007 |
| P698 | PubMed publication ID | 9825953 |
| P2093 | author name string | H A Spiller | |
| P2860 | cites work | Metformin | Q22241437 |
| A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group | Q28202643 | ||
| Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential | Q33471537 | ||
| Acarbose: an alpha-glucosidase inhibitor. | Q33486273 | ||
| Acarbose in the treatment of type I diabetes | Q33486578 | ||
| Insulin Therapy in Phenformin-Associated Lactic Acidosis: A Case Report, Biochemical Considerations and Review of the Literature | Q34155405 | ||
| Type I diabetes mellitus. A chronic autoimmune disease | Q34181699 | ||
| Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists | Q34458152 | ||
| Deaths and paradoxes after intentional insulin overdosage | Q34551119 | ||
| Suicidal insulin overdose managed by excision of insulin injection site. | Q34762258 | ||
| Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? | Q34764739 | ||
| Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs | Q35026523 | ||
| Biguanides and NIDDM | Q36189234 | ||
| Lactic acidosis due to metformin therapy in a low risk patient | Q36722323 | ||
| Inadvertent sulfonylurea-induced hypoglycemia. A dangerous, but preventable condition | Q38231611 | ||
| Drug-induced hypoglycemia. A review of 1418 cases. | Q38602971 | ||
| Oral hypoglycemic agents | Q38700011 | ||
| The danger of high dose sodium bicarbonate in biguanide-induced lactic acidosis: the theory, the practice and alternative therapies | Q39195411 | ||
| Severe hypoglycemia in diabetic patients: frequency, causes, prevention | Q69892179 | ||
| Recovery from metformin overdose | Q70025596 | ||
| Hypoglycaemic reactions in 172 Type 1 (insulin-dependent) diabetic patients | Q70250640 | ||
| Duration of hypoglycemia and need for intravenous glucose following intentional overdoses of insulin | Q70366634 | ||
| Metformin-associated lactic acidosis in Sweden 1977-1991 | Q70493595 | ||
| Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses | Q70589820 | ||
| Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve | Q70824569 | ||
| Hepatic injury caused by acarbose | Q71025992 | ||
| Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects | Q71094681 | ||
| Treatment of metformin-associated lactic acidosis with closed recirculation bicarbonate-buffered hemodialysis | Q71254957 | ||
| Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations | Q71359256 | ||
| Accidental glibenclamide ingestion in an infant: clinical and electroencephalographic aspects | Q71508052 | ||
| Fatal self-poisoning with phenformin | Q71576047 | ||
| A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone | Q71814041 | ||
| Persistent insulin secretion after insulin overdose in a non-diabetic patient | Q72209786 | ||
| [Suicide by insulin] | Q72351205 | ||
| Attempted suicide with phenformin | Q72613007 | ||
| Prolonged hypoglycemia following acetohexamide administration. Report of two cases with impaired renal function | Q72845884 | ||
| Metformin overdose | Q72994933 | ||
| Acarbose-induced acute severe hepatotoxicity | Q73171567 | ||
| Comparison of the effects of acarbose and voglibose in healthy subjects | Q73897182 | ||
| Accidental ingestion of chlorpropamide. Report of a case | Q79116705 | ||
| Lactic acidosis induced by excessive ingestion of metformin | Q93501058 | ||
| Trends in use of oral hypoglycemic agents 1964-1986. | Q39625283 | ||
| The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs | Q39662366 | ||
| Lactic acidosis in biguanide-treated diabetics: a review of 330 cases | Q39718414 | ||
| Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature | Q39827893 | ||
| Disturbances of Potassium Homeostasis in Poisoning | Q40457220 | ||
| Bicarbonate therapy in the treatment of lactic acidosis: medicine or toxin? | Q40596211 | ||
| Pharmacology of alpha-glucosidase inhibition. | Q40655893 | ||
| Treatment of biguanide-induced lactic acidosis: reproposal of the "physiological" approach and review of the literature. | Q40656672 | ||
| Features, prevention and management of acute overdose due to antidiabetic drugs | Q40780201 | ||
| Phenformin-induced lactic acidosis: a forgotten adverse drug reaction | Q40785816 | ||
| Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments | Q40883325 | ||
| Prospective multicenter study of sulfonylurea ingestion in children | Q40888885 | ||
| Five year retrospective evaluation of sulfonylurea ingestion in children | Q41007100 | ||
| Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways | Q41082278 | ||
| A review of the safety and efficacy of acarbose in diabetes mellitus | Q41184991 | ||
| Acarbose: its role in the treatment of diabetes mellitus | Q41206503 | ||
| Acarbose: a review of US clinical experience | Q41399085 | ||
| High K+ rapidly stimulates Ca2+-dependent phosphorylation of three proteins concomitant with insulin secretion from HIT cells | Q41454081 | ||
| Troglitazone | Q41521276 | ||
| Troglitazone | Q41584941 | ||
| Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers. | Q41893825 | ||
| Intentional massive insulin overdose: recognition and management | Q42067876 | ||
| Managing suicidal insulin overdose | Q42331616 | ||
| Characterization of the sulfonylurea receptor on beta cell membranes | Q43487183 | ||
| Surreptitious insulin administration in adolescents with insulin-dependent diabetes mellitus | Q43517551 | ||
| Chlorpropamide intoxication--treatment with peritoneal dialysis | Q44136700 | ||
| Farewell to phenformin for treating diabetes mellitus | Q44412613 | ||
| Self poisoning in diabetic patients | Q44443463 | ||
| Pharmacological studies of a new oral hypoglycemic drug. | Q44586902 | ||
| Phenformin intoxication resulting in lactic acidosis. | Q44804112 | ||
| Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination | Q46952149 | ||
| Unusual problems for the physician in managing a hospital patient who received a malicious insulin overdose | Q48432151 | ||
| Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. | Q48687795 | ||
| Phenformin-induced hypoglycaemia in normal subjects | Q49182705 | ||
| 1996 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. | Q50624313 | ||
| Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. | Q50974010 | ||
| Estimation of the prevalence of non-insulin dependent diabetes mellitus in a rural area of Japan. | Q51579589 | ||
| Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus. | Q51595128 | ||
| Hemiparesis and altered mental status in a child after glyburide ingestion. | Q51993910 | ||
| Estimated glucose requirement following massive insulin overdose in a patient with type 1 diabetes. | Q53384130 | ||
| Full recovery following massive overdose with insulin and thyroxine | Q57135121 | ||
| [Drug consumption in diabetes mellitus (III). Trends of hypoglycemic agents use and consumption in Tarragona, Catalonia, and Spain (1988- 1991). Group for the Study of Diabetes in Tarragona] | Q58417374 | ||
| Dichloracetate in biguanide-induced lacticacidosis | Q66696812 | ||
| Suicidal overdoses with hypoglycemic agents | Q66963760 | ||
| Treament of biguanide-induced lactic acidosis with dichloroacetate. 3 case histories | Q67029279 | ||
| Intravenous infusion of diazoxide in the treatment of chlorpropamide-induced hypoglycemia | Q67405261 | ||
| Letter: Glibenclamide-induced hypoglycaemia | Q67510923 | ||
| Phenformin-associated lactic acidosis: pathogenesis and treatment | Q67707644 | ||
| Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy | Q67967930 | ||
| Recurrent hypoglycemia secondary to drug-dispensing error | Q67997590 | ||
| Attempted suicide by insulin overdose in insulin-dependent diabetic adolescents | Q68131258 | ||
| Metabolic acidosis in a diabetic man | Q68359052 | ||
| Hypoglycemia due to inadvertent dispensing of chlorpropamide | Q68461423 | ||
| Local excision of subcutaneous fat in the management of insulin overdose | Q68888589 | ||
| The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells | Q69010313 | ||
| Metformin and lactic acidosis--a reminder | Q69464522 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 411-424 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Drug Safety | Q15724462 |
| P1476 | title | Management of antidiabetic medications in overdose | |
| P478 | volume | 19 |
| Q22241808 | Adult metformin ingestions reported to Texas poison control centers, 2000-2006 |
| Q42077319 | Case files of the Harvard Medical Toxicology Fellowship at Children's Hospital Boston: an insulin overdose |
| Q44537309 | Clinical pharmacology physiology conference: metformin and lactic acidosis (LA). |
| Q43136201 | Effects of metformin on glucose metabolism of perfused rat livers |
| Q43073026 | Inhibitory effect of voglibose and gymnemic acid on maltose absorption in vivo |
| Q36916325 | Intentional overdose with insulin: prognostic factors and toxicokinetic/toxicodynamic profiles |
| Q34385405 | Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus |
| Q43777182 | The effect of Glurenorm (gliquidone) on lenses and skin in experimental diabetes |
| Q35807254 | The role of sulphonylureas in the management of type 2 diabetes mellitus |
| Q22241557 | Toxic Effects from Metformin Exposure |
Search more.